Medicus Pharma Ltd. (NASDAQ: MDCX) submitted an Investigational New Drug application to the Department of Health, Abu Dhabi for PRECISION-E2 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE